QSI
Quantum-Si incorporated
$1.22
-0.06
(-4.69%)
Mkt Cap
241.34M
Volume
5,728,800
52W Range
0.69-3.1
Sector
Healthcare
Beta
3.22
EPS (TTM)
-0.46 USD
P/E Ratio
-2.16
Revenue (TTM)
1.60M USD
Rev Growth (5Y)
N/A
EPS Growth (5Y)
N/A
Company Description
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Track Record
Showing latest 4 periods • Swipe for more
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.44M | 3.06M | 1.08M | 0 | 0 | 0 | 0 |
| Net Income | (101.34M) | (101.01M) | (95.96M) | (132.44M) | (94.99M) | (36.61M) | (35.80M) |
| EPS | -0.51 | -0.71 | -0.68 | -0.95 | -1.19 | -6.81 | -0.26 |
| Free Cash Flow | (97.23M) | (92.38M) | (99.31M) | (101.30M) | (72.58M) | (33.03M) | (31.95M) |
| FCF / Share | -0.49 | -0.65 | -0.70 | -0.73 | -0.91 | -6.14 | -0.23 |
| Operating CF | (94.72M) | (87.80M) | (94.04M) | (90.56M) | (66.81M) | (32.57M) | (30.71M) |
| Total Assets | 245.61M | 247.87M | 298.25M | 391.49M | 503.23M | 40.59M | 37.41M |
| Total Debt | 4.17M | 12.95M | 15.30M | 17.45M | 8.08M | 1.75M | 0 |
| Cash & Equiv | 21.64M | 49.24M | 133.86M | 84.32M | 35.78M | 36.91M | 32.93M |
| Book Value | 220.23M | 215.42M | 271.62M | 358.71M | 477.03M | 36.09M | 35.46M |
| Return on Equity | -0.46 | -0.47 | -0.35 | -0.37 | -0.20 | -1.01 | -1.01 |
| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 344,000 | 258,000 | 451,000 | 552,000 | 591,000 | 842,000 | 1.19M | 787,000 | 622,000 | 457,000 | 400,000 | 223,000 |
| Net Income | (23.53M) | (21.67M) | (17.61M) | (35.70M) | (28.84M) | (19.19M) | (33.12M) | (25.31M) | (23.10M) | (19.47M) | (22.05M) | (24.73M) |
| EPS | -0.11 | -0.10 | -0.08 | -0.17 | -0.16 | -0.11 | -0.23 | -0.18 | -0.16 | -0.14 | -0.16 | -0.17 |
| Free Cash Flow | (18.52M) | (25.92M) | (16.33M) | (32.92M) | (20.52M) | (27.46M) | (24.32M) | (24.13M) | (19.68M) | (24.31M) | (20.60M) | (22.82M) |
| FCF / Share | -0.09 | -0.12 | -0.08 | -0.16 | -0.11 | -0.15 | -0.17 | -0.17 | -0.14 | -0.17 | -0.15 | -0.16 |
| Operating CF | (18.44M) | (25.64M) | (16.35M) | (32.02M) | (20.20M) | (26.15M) | (22.88M) | (23.15M) | (18.55M) | (23.21M) | (20.97M) | (21.44M) |
| Total Assets | 193.57M | 213.35M | 245.61M | 260.13M | 254.41M | 271.22M | 247.87M | 236.45M | 256.75M | 275.58M | 298.25M | 318.10M |
| Total Debt | 3.25M | 3.71M | 4.17M | 4.61M | 11.14M | 12.05M | 12.95M | 13.82M | 13.65M | 14.48M | 15.30M | 15.45M |
| Cash & Equiv | 23.65M | 36.20M | 21.64M | 30.91M | 22.19M | 37.29M | 49.24M | 42.27M | 59.55M | 53.16M | 133.86M | 93.82M |
| Book Value | 180.20M | 200.74M | 220.23M | 235.16M | 220.98M | 246.92M | 215.42M | 210.52M | 233.26M | 253.77M | 271.62M | 292.06M |
| Return on Equity | -0.13 | -0.11 | -0.08 | -0.15 | -0.13 | -0.08 | -0.15 | -0.12 | -0.10 | -0.08 | -0.08 | -0.08 |
QSI News
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development Program
Head to Head Survey: Quantum-Si (NASDAQ:QSI) versus Twist Bioscience (NASDAQ:TWST)
Neuralink Stock: How to Invest Before the IPO
3 Biotech Stocks Put Traders Are Targeting Today
Quantum-Si Presents Interim Proteus™ Data at World HUPO 2026 Demonstrating a Significant Step Change in Performance Compared to Platinum® Pro
Quantum-Si Announces Detection of 18 Amino Acids Using a Developmental Sequencing Kit on Proteus™
Quantum-Si Expands Proteus™ Roadshow with Additional U.S. and European Cities
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Quantum-Si incorporated (QSI) Q2 2026 Earnings Call Transcript
Quantum-Si Q2 Earnings Call Highlights